Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000422717 | SCV000527879 | likely benign | not specified | 2016-05-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000422717 | SCV000697938 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000636755 | SCV000758196 | likely benign | Microcephaly, normal intelligence and immunodeficiency | 2023-07-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000636755 | SCV002045932 | likely benign | Microcephaly, normal intelligence and immunodeficiency | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000581041 | SCV002646617 | likely benign | Hereditary cancer-predisposing syndrome | 2015-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000636755 | SCV001457040 | uncertain significance | Microcephaly, normal intelligence and immunodeficiency | 2020-01-24 | no assertion criteria provided | clinical testing |